Insider Sales Surge in Crypto and Biotech — What It Means for Your Portfolio
Multiple insiders dumped over $2.5 million in crypto and biotech stocks this week, signaling potential red flags for investors.
Cowlpane has published 8 articles on portfolio risk — primarily in Markets, Economy, Trading , with coverage from 2026. Sourced from global financial publications.
Multiple insiders dumped over $2.5 million in crypto and biotech stocks this week, signaling potential red flags for investors.
CFO turnover at Eastplats and Pfizer could reshuffle sector sentiment, prompting investors to rethink exposure to junior miners and big‑pharma stocks.
The SRA’s suspension of ICC chief prosecutor Karim Khan on May 23 rattles legal‑services stocks and forces investors to rethink exposure to international law firms and ESG‑linked funds.
Silicon Valley's hidden dominance could reshape inflation dynamics and fiscal policy, forcing investors to rethink exposure to platform‑centric assets.
The U.S. hits a Cuban‑era proxy with sanctions, sparking a shift in how left‑wing NGOs and allied regimes might fund their agendas.
A two‑day plunge in key chip makers rattles tech exposure and fuels fresh debate on Fed policy and inflation pressures.
A single Reddit comment reveals a surprising weakness in business economics curricula, prompting investors to rethink skill development before market moves.
I just cracked the paradox of chasing dividends while the Fed keeps hiking, and it’s a wild ride for my portfolio.